Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company opera... Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. Its lead projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.4701 | -28.1497005988 | 1.67 | 1.67 | 1.15 | 131253 | 1.31012718 | CS |
4 | 0.0599 | 5.25438596491 | 1.14 | 1.8 | 1.06 | 172310 | 1.41530705 | CS |
12 | 0.4999 | 71.4142857143 | 0.7 | 7.4899 | 0.5863 | 2707158 | 2.61626386 | CS |
26 | -2.0901 | -63.5288753799 | 3.29 | 7.4899 | 0.46 | 1183245 | 2.59910716 | CS |
52 | -0.6801 | -36.1755319149 | 1.88 | 17.49 | 0.46 | 1200476 | 5.56967158 | CS |
156 | -18.8001 | -94.0005 | 20 | 20 | 0.46 | 468627 | 5.88666913 | CS |
260 | -152.3001 | -99.2183061889 | 153.5 | 157.4 | 0.46 | 599827 | 17.60198078 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions